KRAS and non-small cell lung carcinoma: As shown in Fig. 3a–c, low expression of SDPR was associated with shorter OS in NSCLC patients as well as in KRAS-mutant group, based on GEO dataset and lung cancer microarray (GSE72094, HLugA180Su06, P < 0.05).